SEATTLE, Jan. 30, 2018 /PRNewswire/ -- Quorum Review IRB, the largest and most preferred central IRB, announces a major release of Q Consent™: a cloud-based electronic informed consent (eConsent) solution that increases consent accuracy, simplifies study startup, and ensures positive and engaging consenting experience for participants. The new Q Consent release provides a complete view of any study regardless of the IRB of record. All eConsent-enabled sites now appear in an aggregate dashboard view to provide study sponsors with a complete outlook of how any study is progressing.
Quorum will exhibit at SCOPE Summit for clinical ops executives in Orlando, February 13-15, and provide live Q Consent demonstrations. Study sponsors are invited to request either an online demo or to meet in person at SCOPE.
"We are proud that our Q Consent tool continues to reshape the research industry. We firmly believe that this is the best eConsent solution to efficiently help sponsors, empower sites, and better engage participants with the clinical trials process," says Cami Gearhart, CEO of Quorum. "Sponsors will find this new release helpful for tracking and remote monitoring of large central studies for all eConsent-enabled sites. Q Consent tips the scales in the direction of what eConsent should promise researchers—faster study startup and more affordable automation of electronic informed consent processes."
Developed by Kinetiq, the technology and consulting division of Quorum, Q Consent is the first and only IRB-integrated eConsent solution.
Highest Level of eConsent Compliance and Security
Q Consent meets or exceeds the most stringent eConsent privacy and security requirements, including HIPAA, HITECH, and FDA 21 CFR Part 11. Plus, this is the only eConsent solution that complies with the Children's Online Privacy and Protection Act (COPPA) and the Canadian Personal Information Protection and Electronic Documents Act (PIPEDA).
All eConsent Tools Reviewed
Quorum has developed a practical approach to eConsent review that fits any eConsent tool on the market. Quorum incorporates years of experience, industry considerations, and the FDA's final eConsent guidance to develop a submission process that provides clear direction on what and how to submit to ensure appropriate IRB review.
About Quorum Review IRB
Discover more at our website.
Contact:
Scott Smith
Director of Marketing
Quorum Review IRB
(206) 448-4082
[email protected]
SOURCE Quorum Review IRB
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article